Fresh off of the heels of a shakeup at the CDC over vaccine recommendations, many Americans still question the necessity and ...

Moderna’s Covid vaccine for children has been given full FDA approval, making it the first such shot for kids in the U.S.

Moderna, Inc. (MRNA) on Thursday announced that the U.S. Food and Drug Administration (FDA) has fully approved its COVID-19 ...

Moderna is seeking emergency use authorization from the FDA for its Covid-19 vaccine for children 6 months through 5 years of age. 24/7 Live San Francisco East Bay South Bay Peninsula North Bay.

The FDA this week fully approved Moderna’s COVID-19 vaccine for children aged 6 months to 11 years but limited the approval ...

The U.S. Food and Drug Administration approved "Spikevax," Moderna's vaccine for children aged 6 months to 11 years old. The ...

The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 ...

Emergency use authorization was also conferred on diagnostic kits to detect emerging infectious diseases such as MERS, H7N9 influenza, Ebola, and Zika. Prior to the COVID-19 pandemic, 33 of these ...

The first COVID-19 vaccine was distributed under an Emergency Use Authorization. More than seven months later, actual approval hasn’t been granted.

To win emergency use authorization, or EUA, drug or device makers may present the FDA with less evidence of a product’s safety and effectiveness than is required for full approval.

FDA withdraws emergency use authorization of COVID drug because it is unlikely to be effective against new variants. Evusheld doesn't neutralize against several omicron subvariants, the FDA says.

The FDA’s emergency use authorization (EUA) program for rapid antigen tests for the COVID-19 pandemic is coming to an end, but few rapid antigen test makers have laid out clear plans regarding the ...